Perchlorate is an inorganic anion used for a variety of products such as road flares, explosives, pyrotechnics, and solid rocket propellant ([@b38-ehp0114-001865]). Perchlorate can also form naturally in the atmosphere, leading to trace levels of perchlorate in precipitation ([@b17-ehp0114-001865]). Natural processes are considered to concentrate perchlorate in some locations such as regions of west Texas ([@b17-ehp0114-001865]) and northern Chile ([@b51-ehp0114-001865]). A combination of human activities and natural sources has led to the widespread presence of perchlorate in the environment. As of November 2005, perchlorate was detected in drinking water samples from 4.1% of community water supplies in 26 different states, with levels ranging from the method detection limit of 4 μg/L to a maximum at 420 μg/L \[[@b53-ehp0114-001865]\]. Most of this drinking-water contamination is likely due to contaminated source waters, although in rare instances perchlorate formation has been reported to occur in water distribution systems ([@b26-ehp0114-001865]). Additionally, perchlorate exposure from the diet is probable because of the contamination of milk ([@b30-ehp0114-001865]), vegetables ([@b44-ehp0114-001865]), fruit ([@b45-ehp0114-001865]), grain ([@b46-ehp0114-001865]), and forage crops ([@b27-ehp0114-001865]). Perchlorate contamination has also been reported in dietary supplements and flavor enhancers ([@b47-ehp0114-001865]).

Trace levels of perchlorate in the environment leads to human exposure. Direct measurement of perchlorate in biological samples collected from people \[[@b39-ehp0114-001865]\] is considered an excellent assessment of their exposure. We recently assessed perchlorate exposure in a nationally representative sample of 2,820 U.S. residents, ≥ 6 years of age, who participated in the National Health and Nutrition Examination Survey (NHANES) during 2001 and 2002 ([@b6-ehp0114-001865]).

Environmental perchlorate exposure is of potential health concern because much larger doses of perchlorate have been shown to competitively inhibit iodide uptake ([@b23-ehp0114-001865]; [@b58-ehp0114-001865]). Populations with low intake of iodine or increased demand for iodine may be more vulnerable to inhibition of iodide uptake. Sustained inhibition of iodide uptake can lead to hypothyroidism, although perchlorate-induced changes to thyroid function have not been previously demonstrated in any human population exposed to perchlorate, even at doses as high as 0.5 mg/kg body weight per day ([@b39-ehp0114-001865]). The thyroid plays a crucial role in energy homeostasis and neurologic development. Hypothyroidism can lead to metabolic problems in adults and abnormal development during gestation and infancy ([@b9-ehp0114-001865]). Severe hypothyroidism due to iodine deficiency during pregnancy is a preventable cause of cretinism, a permanent cognitive impairment of the developing fetus ([@b22-ehp0114-001865]). Mild hypothyroidism during pregnancy has been associated with subtle cognitive deficits in children ([@b24-ehp0114-001865]; [@b31-ehp0114-001865]), leading the NRC to recommend that consideration be given to adding iodide to all prenatal vitamins ([@b39-ehp0114-001865]). Therefore, we examined relationships between urinary perchlorate and serum thyroid hormones in men and women, ≥ 12 years of age, who participated in NHANES 2001--2002.

Subjects and Methods
====================

Study design
------------

NHANES is conducted by the National Center for Health Statistics of the Centers for Disease Control and Prevention (CDC). This survey is designed to assess the health and nutrition status of the civilian, non-institutionalized U.S. population. NHANES uses a complex multistage probability sampling designed to be representative of the U.S. population based on age, sex, race/ethnicity, and income. Data reported in the present study were collected using an extensive household interview addressing health conditions and health-related behaviors and a standardized physical examination including medical blood and urine tests, which were conducted in mobile examination centers. NHANES 2001--2002 was conducted in 30 locations throughout the United States. Overall, the survey interview response rate was 83.9% and the exam response rate was 79.6%. A full description of the NHANES survey is available on the NHANES website ([@b14-ehp0114-001865]). The study protocol was reviewed and approved by the CDC institutional review board; additionally, informed written consent was obtained from all subjects before they took part in the study.

Urinary perchlorate levels were measured by the Division of Laboratory Sciences, National Center for Environmental Health, on a representative random one-third subsample consisting of 2,820 study participants (males and females), ≥ 6 years of age ([@b6-ehp0114-001865]). For ages ≥ 12 years, 2,517 persons were in the random subsample. Serum levels of thyroid stimulating hormone (TSH) and total thyroxine (T~4~) were only available for 2,299 participants ≥ 12 years of age.

Demographic variables
---------------------

Sociodemographic data were self-reported by study participants. Race/ethnicity was derived from self-reported questionnaire data and categorized as non-Hispanic white, non-Hispanic black, Mexican American, and "other." Each of these race/ethnicity categories was used in the regression modeling. Non-Hispanic whites were used as the referent group in regression analysis.

Laboratory methods
------------------

During the physical examinations, whole blood and spot urine specimens were collected from participants, aliquoted, and stored cold (2--4°C) or frozen until shipment. Whole blood was collected into a red-top 15-mL Vacutainer tube, mixed, allowed to clot 30--45 min, and centrifuged; approximately 1 mL serum was stored frozen in a cryovial for future analysis for TSH and T~4~. Serum samples collected in 2001 were assayed for TSH and T~4~ by the Coulston Foundation (Alamogordo, NM) using a microparticle enzyme immunoassay for the quantitative determination of TSH, and a Hitachi 704 chemistry analyzer (Hitachi Chemical Diagnostics, Mountain View, CA) for the quantitative determination of T~4~ ([@b13-ehp0114-001865]). Serum samples collected in 2002 were assayed for TSH and T~4~ by Collaborative Laboratory Services (Ottumwa, IA) using a chemiluminescent immunoassay (Access Immunoassay System; Beckman Instruments, Fullerton, CA) ([@b13-ehp0114-001865]). The National Center for Health Statistics evaluated the TSH and T~4~ data sets from the two laboratories and determined that the values are comparable across the 2 years.

Surplus urine samples from NHANES 2001--2002 were shipped on dry ice to the Division of Laboratory Sciences and analyzed for perchlorate, thiocyanate, and nitrate using ion chromatography tandem mass spectrometry ([@b6-ehp0114-001865]; [@b54-ehp0114-001865]). These samples were stored frozen (−70°C) for up to 4 years before perchlorate analysis. Experiments evaluating storage at −70°C for \> 2 years indicated no changes in urinary levels of this analyte ([@b6-ehp0114-001865]). Reported results for all assays met the division's quality control and quality assurance performance criteria for accuracy and precision \[similar to specifications outlined by [@b55-ehp0114-001865]\]. Urine samples from the same study participants had previously been analyzed for iodine using inductively coupled plasma mass spectrometry ([@b11-ehp0114-001865]).

Statistical analysis
--------------------

Initial multiple regression analysis found perchlorate to be a significant predictor of both T~4~ and log TSH in women, but perchlorate did not predict either T~4~ or log TSH in men (data not shown). Therefore, we present subsequent analysis focused on women.

Of the 1,318 women ≥ 12 years of age, 92 had missing TSH and T~4~ values, leaving 1,226. Of these 1,226 women, 91 were excluded from analysis because they reported a history of thyroid disease or current use of thyroid medications, leaving 1,135 women. Of these 1,135 women, 3 had extreme values of T~4~ and/or TSH and were excluded. One of these women had a total T~4~ of 27 μg/dL and a TSH of 0.04 IU/L. This woman was clearly hyperthyroid and thus was excluded from the analysis. Two other women had very high TSH levels (43 and 68 IU/L) and were excluded. Of the remaining 1,132 women, 21 had missing perchlorate measurements, leaving a sample size of 1,111 women.

The major design variables for NHANES are age, sex, race/ethnicity, and income related to the poverty level. The values of these variables for the initial 1,318 women and the final 1,111 women, respectively, are as follows: mean age, 41.6 and 39.8 years; percent non-Hispanic whites, 70.8% and 69.4%; percent non-Hispanic blacks, 11.8% and 12.5%; percent Mexican Americans, 7.0% and 7.0%; and percent below the poverty level, 13.9% and 14.9%.

We chose covariates for the multiple regression analyses that are known to be or likely to be associated with T~4~ or TSH. We selected a broad number of covariates to evaluate the independence of the perchlorate relationship. These covariates were age, race/ethnicity, body mass index (BMI), serum albumin, serum cotinine (a marker of tobacco smoke exposure), estimated total caloric intake, pregnancy status, postmenopausal status, premenarche status, serum C-reactive protein, hours fasting before sample collection, urinary thiocyanate, urinary nitrate, and use of selected medications.

For these covariates, [Table 1](#t1-ehp0114-001865){ref-type="table"} provides means (or geometric means if lognormally distributed) for continuous variables, percent in category for categorical variables, and number of missing results for each covariate. Thyroid function has been previously reported to vary with the constitutional variables of age, race, sex, pregnancy, and menopause ([@b9-ehp0114-001865]). Serum cotinine is a marker of tobacco smoke exposure, and smoking is associated with altered thyroid function ([@b5-ehp0114-001865]). We included serum C-reactive protein as a marker for inflammatory conditions that have been associated with alterations in thyroid function. Both total caloric intake \[based on a 24-hr dietary recall survey and a U.S. Department of Agriculture (USDA) database (Food and Nutrition Database for Dietary Studies; [@b52-ehp0114-001865])\] and BMI are related to thyroid function, but the interrelationship as to cause or effect is unclear.

Serum albumin was included in our analysis as a possible surrogate for T~4~ serum protein binding. NHANES 2001--2002 included total T~4~ measurements but not free T~4~ measurements; total T~4~ varies with the concentrations of specific binding proteins. Concentrations of these proteins can change with physiologic state and health conditions. Free T~4~ varies less with such protein concentration changes than does total T~4~. Serum albumin accounts for 15--20% of T~4~ binding, with thyroid binding protein and prealbumin (not measured in NHANES) accounting for the remaining percentage ([@b43-ehp0114-001865]). Thyroid autoantibody measurements were not available for 2001--2002. For autoantibodies to affect the relationship between perchlorate and T~4~ or TSH, presence of autoantibodies would have to correlate with perchlorate levels. We have found no such correlation in the literature and we are unaware of a rationale for such an association.

Medications known to affect thyroid function were also considered. As noted above, women taking medication containing thyroid hormone (e.g., levothyroxine) or antithyroid drugs (e.g., methimazole or propylthiouracil) were excluded. Use of beta-blockers, estrogen formulations, steroids, and furosemide were each modeled using an indicator variable in the regressions. An "other drug" category was also modeled by an indicator variable. This "other drug" category consisted of a heterogeneous group of other medications that have possible effects on thyroid function, protein binding, or measurements, including salicylates, dopaminergics, anticonvulsants and barbiturates, narcotic analgesics, androgenic agents, lithium, and several others (a total of 28 drug codes).

We included the log of urinary creatinine in the models to adjust for variable water excretion. A nonlinear relationship was evaluated by adding the square of the log of perchlorate to final models, but it was not significant. Models were also checked for significance of interaction terms involving main effects. We examined partial regression plots to identify any unduly influential data points; no unduly influential points were found. Indicator variable coefficients in the models (e.g., for non-Hispanic blacks) were interpreted as follows: 1 = group member, and 0 = not a group member. Urine samples were collected in three sessions of the day from 0800 hours through 2200 hours. Mean perchlorate levels were not statistically different across sessions (*p* = 0.49).

We examined univariate statistics and distribution plots for each dependent and independent variable to look for outliers and to assess the distribution shape. TSH, perchlorate, cotinine, BMI, urinary thiocyanate, urinary nitrate, and C-reactive protein were log~10~-transformed to normalize their distributions.

Regression models, including log of perchlorate as one of the predictor variables, were constructed separately for thyroxine and log of TSH. For the initial phase of analysis, we used ordinary least-squares regression (OLS) (SAS Proc Reg, version 9.0; SAS Institute, Cary, NC) and purposefully did not adjust for the NHANES complex survey design in order to obtain a broad group of potentially significant predictor variables. Forward stepwise and backward elimination procedures were used on both population-weighted and unweighted data. The entry *p*-value for forward elimination models was 0.10 and the retaining *p*-value for backward elimination was 0.10 in order to identify significant and borderline significant predictors. The forward stepwise and backward elimination approaches produced models that were generally in good agreement.

This OLS analysis produced a generous list of significant and borderline-significant variables for regression analysis using SUDAAN (version 9.0.1; Research Triangle Institute, Research Triangle Park, NC), which provides an analysis that adjusts for the complex survey design. SUDAAN regression models were tested using a manual backward elimination approach starting with the variables obtained from the OLS regression modeling. Selected variables that were excluded in the SUDAAN backward elimination process were added to the final model to ensure they were not significant. The stability of the perchlorate coefficient was monitored during the SUDAAN backward elimination process.

In the main SUDAAN regression analysis, we used population weights to represent women ≥ 12 years of age in the U.S. population for the years 2001 and 2002. In addition, we performed separate regression analyses with SUDAAN using unweighted data and verified that regression coefficients were in good agreement with those obtained using population weights. Reported regression model results in the tables use the population-weighted analysis.

Women were categorized based on a urinary iodine cut point of 100 μg/L and analyzed separately. The 100 μg/L cut point was used based on the World Health Organization (WHO) definition of sufficient iodine intake in populations ([@b56-ehp0114-001865]). The WHO noted that the prevalence of goiter begins to increase in populations with median urinary iodine \< 100 μg/L. A urine iodine level of 100 μg/L represents about the 36th percentile of urinary iodine concentrations in women living in the United States ([@b11-ehp0114-001865]). Women with lower iodine intake could be more vulnerable to perchlorate's effects to impair iodine uptake. From this analysis, the significance of urinary perchlorate as a predictor of thyroid function in women was found to be largely determined by women with urinary iodine \< 100 μg/L. Consequently, we report here results for women divided into groups based on urinary iodine levels.

Compared to the use of average multiple spot urine measurements or 24-hr urine specimens, the use of a single spot urine for perchlorate and iodine measurement has more imprecision in estimating true urine levels ([@b2-ehp0114-001865]). This imprecision is a source of random error (not bias) and therefore decreases statistical power to detect an association between perchlorate and either TSH or T~4~ compared to these other urine collection approaches.

Results
=======

For all women ≥ 12 years of age, multiple regression analysis found urinary perchlorate to be a significant predictor of serum TSH and a significant predictor of serum T~4~ (data not shown). Because low iodine levels had potential to affect the relationship of perchlorate with T~4~ and TSH, women with urinary iodine \< 100 μg/L were analyzed separately from women with urinary iodine ≥ 100 μg/L. Results of this analysis are presented in [Tables 2](#t2-ehp0114-001865){ref-type="table"} and [3](#t3-ehp0114-001865){ref-type="table"} for T~4~ and in [Tables 4](#t4-ehp0114-001865){ref-type="table"} and [5](#t5-ehp0114-001865){ref-type="table"} for TSH.

For women with urinary iodine \< 100 μg/L, multiple regression analysis found perchlorate to be a significant predictor (*p* \< 0.0001) of T~4~ with a coefficient for log perchlorate of −0.8917. The result of regression of T~4~ on perchlorate and urinary creatinine without other covariates yielded a coefficient of −0.8604 (*p* \< 0.0001). Perchlorate was also a significant predictor (*p* = 0.0010) of log TSH with a coefficient of 0.1230. The result of regression of log TSH on perchlorate and urinary creatinine without other covariates found a coefficient of 0.1117 (*p* = 0.0031). The signs of these coefficients are coherent, with increased perchlorate associated with less production of T~4~ and an increase in TSH to stimulate additional T~4~ production. For women with urinary iodine ≥ 100 μg/L, perchlorate was not a significant predictor of T~4~ (*p* = 0.5503) but remained a significant predictor of log TSH (*p* = 0.0249). The regression analysis results in [Tables 2](#t2-ehp0114-001865){ref-type="table"}--[5](#t5-ehp0114-001865){ref-type="table"} include variables that were borderline significant (0.05 ≤ *p* \< 0.10) to give ample opportunity for other variables to explain variance and better evaluate the independence of the perchlorate effect.

Regression results for men (not shown) indicated that perchlorate was not a significant predictor of either T~4~ or log TSH. This finding also held when examining men with urinary iodine levels \< 100 μg/L.

From the regression coefficients for women with urinary iodine \< 100 μg/L, we calculated the predicted effect size (i.e., the change in T~4~ and TSH) for different levels of perchlorate exposure. We chose perchlorate levels corresponding to the 5th, 10th, 25th, 50th, 75th, 90th, and 95th percentiles of urinary perchlorate in women ≥ 12 years of age. The minimum and maximum perchlorate values are observed results for this population sample; they are not estimates of the 0th and 100th percentiles for the U.S. population. As such, they would be expected to change in another population sample. The effect size was calculated from the difference between the minimum level of perchlorate measured in women and the level of perchlorate corresponding to the specific percentile. For example, the 50th percentile of urinary perchlorate for women was 2.9 μg/L and the minimum level was 0.19 μg/L. Increasing exposure from 0.19 μg/L to 2.9 μg/L would result in a predicted decrease in T~4~ of 1.06 μg/dL.

For TSH, one more step is needed in the calculation. Because TSH was modeled as log TSH, the change in TSH from a given change in perchlorate depends on the starting level of TSH. In our calculations we used the approximate 50th and 90th percentiles of TSH as starting points to estimate the predicted perchlorate effect size for TSH. Results of these calculations for T~4~ and TSH are presented in [Table 6](#t6-ehp0114-001865){ref-type="table"}. For comparison, the normal range is 5--12 μg/dL for T~4~ and 0.3--4.5 IU/L for TSH.

To search for a threshold for the perchlorate relationship with T~4~ and TSH, piecewise regression models ([@b40-ehp0114-001865]) were fit to the data. No inflection point was found for the perchlorate relationship with T~4~ or TSH. However, statistical power is limited to detect such a threshold, if present.

Discussion
==========

Increased urinary perchlorate was associated with increased TSH and decreased T~4~ for women with urinary iodine levels \< 100 μg/L, a group possibly more susceptible to competitive inhibition of thyroid iodine uptake by perchlorate. The statistically significant associations of urinary perchlorate with decreased serum T~4~ and increased serum TSH were consistent with competitive inhibition of iodide uptake.

For women with urine iodine ≥ 100 μg/L, perchlorate was also a statistically significant predictor for TSH but not for T~4~. Greater iodine intake may have diminished the effect of perchlorate on T~4~ in these women. The significant association with TSH, but not with T~4~, in this group may be due to the greater sensitivity of TSH to impairment of thyroid function; that is, normal T~4~ levels are maintained by increasing TSH to compensate for impaired thyroid function.

Predicted changes in serum TSH and T~4~ with increasing perchlorate exposure ([Table 6](#t6-ehp0114-001865){ref-type="table"}) can span a notable portion of the normal medical range of TSH and T~4~ values. Compared with a urine level of 0.19 μg/L, urinary perchlorate of 13 μg/L (95th percentile) yields a predicted decrease in T~4~ of 1.64 μg/dL. The normal range for T~4~ is 5--12 μg/dL. A similar exposure would increase TSH by 2.12 IU/L for a woman starting with a TSH level of 3.11 IU/L (90th percentile for TSH in women ≥ 12 years of age). The normal range for TSH is 0.3--4.5 IU/L. Effect size estimates that start with the 90th percentile of TSH have more uncertainty than estimates starting with the 50th percentile because the predicted TSH levels fall further from the central portions of the original data.

The mechanism of perchlorate's effect is competitive inhibition of iodide uptake by the thyroid ([@b15-ehp0114-001865]; [@b57-ehp0114-001865]). Based on this mechanism, individuals with less iodide available to compete with perchlorate may be more vulnerable to impaired iodide uptake. Chronically impaired iodide uptake could lead to changes in serum thyroid hormones, consistent with the increased TSH and decreased T~4~ we find associated with increased perchlorate exposure in women with urinary iodine \< 100 μg/L. The [@b56-ehp0114-001865] has identified median urinary iodine levels ≥ 100 μg/L as indicating sufficient iodine intake for a population. Based on concerns about adequate iodine intake, the [@b39-ehp0114-001865] recently recommended that consideration be given to adding iodine to all prenatal vitamins.

In the present study, perchlorate was not found to be a significant predictor of T~4~ or TSH in men. Previous studies report that women have a much higher risk of goiter than do men, especially in populations with marginal iodine intake ([@b34-ehp0114-001865]). The increased vulnerability of women may partially be caused by increased susceptibility to auto-immune thyroid disease in women, the increased demands on the thyroid during pregnancy, or the effect of estrogens on thyroid function. Estradiol has been shown to block TSH-induced sodium/iodide symporter (NIS) expression in the FRTL5 rat follicular cell line ([@b19-ehp0114-001865]). Impaired NIS expression could lead to reduced ability of the thyroid follicular cells to import iodide, and thus an increased vulnerability to NIS-inhibitors such as perchlorate. Also, estrogens increase T~4~-binding globulin and thus increase the demand for T~4~ so that free T~4~ levels can remain constant.

Covariates in the regression models predicted T~4~ and TSH levels in a manner generally consistent with previous studies. We found that estrogen use was a significant, independent, and positive predictor of T~4~ in both low and sufficient iodine models of women ≥ 12 years of age, but was not a significant predictor in either of the TSH models. Similar to estrogen use, pregnancy was a significant or borderline significant predictor of T~4~ but not TSH. Both estrogen use and pregnancy raise estrogen levels, increase thyroid binding proteins, and increase serum T~4~ concentrations ([@b21-ehp0114-001865]). Menopause lowers estrogen levels and was a significant predictor of T~4~ in the regression for women with urinary iodine levels \< 100 μg/L.

In NHANES III (1988--1994), non-Hispanic blacks were reported to have lower TSH than other groups, and Mexican Americans had higher T~4~ levels than non-Hispanic blacks and whites ([@b25-ehp0114-001865]). The models for TSH and T~4~ in the present study were consistent with these previous findings concerning race/ethnicity. Non-Hispanic blacks have also been shown to have lower urinary perchlorate levels than non-Hispanic whites, although the reason for this difference is not known ([@b6-ehp0114-001865]). Age was positively associated with TSH in women with urinary iodine levels ≥ 100 μg/L, but not significant for women with urinary iodine levels \< 100 μg/L. A positive association of age and TSH was seen in NHANES III and other studies ([@b12-ehp0114-001865]; [@b25-ehp0114-001865]).

BMI was significant in the TSH model for women with urinary iodine levels ≥ 100 μg/L, and total caloric intake was significant in the T~4~ model for women with urinary iodine levels \< 100 μg/L. Thyroid function clearly has an effect on BMI, as seen clinically and documented in populations ([@b41-ehp0114-001865]). The reverse is also true, because BMI and total caloric intake can influence the hypothalamic--pituitary--thyroidal axis, although usually at the extremes of body weight and caloric intake ([@b1-ehp0114-001865]; [@b10-ehp0114-001865]; [@b16-ehp0114-001865]; [@b37-ehp0114-001865]; [@b36-ehp0114-001865]). Total caloric intake in NHANES is a 24-hr recall of food intake. Depending on how well recent intake reflects long-term intake, total caloric intake may parallel the effect of BMI, which was not seen in the present study. Increased caloric intake is known to increase thyroid hormone disposition through deiodination pathways ([@b10-ehp0114-001865]; [@b16-ehp0114-001865]), increasing the conversion of T~4~ to the active form, triiodothyronine (T~3~), and increasing conversion of T~3~ to inactive forms. The effect of changes in calories and carbohydrate composition of the diet on thyroid disposition may have different short- and long-term effects on T~3~ and T~4~ levels. In the present study, hours of fasting before sample collection was a borderline significant predictor in one regression model: T~4~ in women with sufficient iodine. Fasting for 60 hr can reduce TSH in humans, but fasting for shorter periods has unknown effects on thyroid function.

Beta-blocker drugs are commonly used to treat hypertension and other cardiovascular conditions. Beta-blockers inhibit the conversion of T~4~ to the more active form, T3, and increase serum TSH ([@b29-ehp0114-001865]). Use of these drugs was positively associated with TSH in the regression for women with urinary iodine \< 100 μg/L. Serum C-reactive protein was positively associated with T~4~ in women in each of the iodine groups. C-reactive protein is an acute phase reactant protein increased in many inflammatory conditions in response to production of tissue-generated cytokines, particularly interleukin-6, and has been used as a marker for both specific and systemic low-level inflammation conditions. It is unclear if C-reactive protein is associated with thyroid function other than thyroiditis ([@b28-ehp0114-001865]; [@b42-ehp0114-001865]; [@b50-ehp0114-001865]). However, the stimulus for C-reactive protein, interleukin-6, has a firm inverse relationship with serum T~3~ in nonthyroidal illnesses. Also, C-reactive protein and serum T~4~ binding proteins are synthesized by the liver; C-reactive protein may vary with an unrecognized health or physiologic condition that affects the synthesis of both proteins. The association of C-reactive protein and T~4~ in our study is unclear.

Other variables that are known to possibly affect thyroid function or measurements were not significant predictors in the regression models, including the categories of medications (other than estrogen use and beta-blockers), serum albumin, and serum cotinine. Generally, other medication categories were small and unlikely to have significant effects. Serum albumin did not appear in the final models. Factors such as estrogen use that increase protein binding of thyroid hormones may have accounted for variance in T~4~ due to protein binding that serum albumin may have otherwise explained. Serum cotinine is a marker of tobacco smoke exposure, and smoking is associated with altered thyroid function ([@b4-ehp0114-001865]; [@b5-ehp0114-001865]). However, tobacco smoke also contains other factors that can inhibit TSH secretion ([@b3-ehp0114-001865]), and perhaps is an explanation for the absence of an association of serum cotinine with either TSH or T~4~.

Cyanide in tobacco smoke is metabolized to thiocyanate, a competitive inhibitor of iodide uptake ([@b49-ehp0114-001865]). Also, nitrate from dietary sources and from formation by intestinal bacteria can compete with iodide. *In vitro* studies indicate that perchlorate is a more potent inhibitor of human NIS, with potencies 15, 30, and 240 times greater than thiocyanate, iodide, and nitrate, respectively ([@b49-ehp0114-001865]). Thus, the ability of NIS to transport adequate amounts of iodide depends on the relative concentrations of these competing anions. Based on the relative concentrations of perchlorate, nitrate, and thiocyanate likely to be found in human serum, several researchers have predicted that nitrate and thiocyanate are more likely than perchlorate to impair thyroid function ([@b18-ehp0114-001865]; [@b20-ehp0114-001865]). Thiocyanate-induced NIS inhibition is a plausible explanation of the association of smoking with goiter in populations with low iodine intake ([@b32-ehp0114-001865]) and is analogous to the association of perchlorate exposure with thyroid hormone levels observed in our study. However, in women with urinary iodine levels ≥ 100 μg/L, urinary thiocyanate was negatively associated with serum TSH, a direction unexpected based on a mechanism of NIS inhibition. The explanation for this is unclear. Urinary nitrate was negatively associated with serum T~4~ in women with urinary iodine levels ≥ 100 μg/L, a direction consistent with inhibition of NIS. Goitrogenic effects of nitrate intake in animal studies have been observed ([@b58-ehp0114-001865]), but there are few studies in humans.

Recently the [@b39-ehp0114-001865] evaluated the potential health effects of perchlorate ingestion. Based on studies of long-term treatment of hyperthyroidism and clinical studies of healthy adults, the NRC panel estimated that a perchlorate dose of \> 0.40 mg/kg/day would be required to cause hypothyroidism in adults, although lower doses may lead to hypothyroidism in sensitive subpopulations ([@b39-ehp0114-001865]).

Comparison of our results to previous studies requires consideration of *a*) target population group studied, *b*) estimated dose of perchlorate, *c*) duration of exposure to perchlorate dose, and *d*) sample size (statistical power). First, for men, we found no relationship with perchlorate and T~4~ or TSH. This finding is in general agreement with predicted effects of this level of perchlorate exposure based on reported studies of exposure in men. [@b35-ehp0114-001865] administered 10 mg perchlorate daily (\~ 0.14 mg/kg) to iodine-sufficient adult males for 14 days and found a 10% decrease in radioactive iodine uptake (RAIU), but with no change in TSH or free T~4~.

[@b23-ehp0114-001865] administered perchlorate to 16 male and 21 female volunteers for 14 days, and found increasing RAIU inhibition for doses between 0.02 and 0.5 mg/kg/day, with no perchlorate-related change in TSH or free T~4~. An unknown number of women in that study may have had urinary iodine \< 100 μg/L, but if the women were typical of the U.S. population ([@b11-ehp0114-001865]), the predicted number of women with low urinary iodine would be 7--8. [@b8-ehp0114-001865] administered perchlorate to 13 iodine-sufficient male and female volunteers at daily doses of 0.5 mg and 3 mg for 6 months, and found no change in RAIU, TSH, or free T~4~. Two other studies have also found that workers exposed to perchlorate intermittently for long periods did not have significant changes to serum TSH or T~4~ levels ([@b7-ehp0114-001865]; [@b33-ehp0114-001865]). These study populations were either exclusively ([@b7-ehp0114-001865]) or predominantly ([@b33-ehp0114-001865]) male.

For women, only two perchlorate studies have focused on women or included a large percentage of women. A recent study of 184 pregnant Chilean women, with mean urinary perchlorate levels near the 99th percentile for women in NHANES 2001--2002, found no perchlorate relationship with thyroid function ([@b48-ehp0114-001865]). Of these 184 women, 181 had mean urinary iodine levels ≥ 100 μg/L and only 3 had mean levels \< 100 μg/L. Therefore, the results of [@b48-ehp0114-001865] would compare to the present results for women with urinary iodine levels ≥ 100 μg/L. Urinary iodine levels in the Chilean study population (median 269 μg/L) were higher than urinary iodine levels found in the NHANES 2001--2002 population \[median 168 μg/L; 95% confidence interval, 159--178 μg/L\]. The Chilean women ([@b48-ehp0114-001865]) were also pregnant, which increases the variability in T~4~ and TSH. This increased variability would make an association between perchlorate and thyroid function harder to find. The second study with a large percentage of women was [@b23-ehp0114-001865] discussed above. These two studies are compared with the present study in [Table 7](#t7-ehp0114-001865){ref-type="table"}.

[Table 7](#t7-ehp0114-001865){ref-type="table"} indicates that our study is the first to target and separately analyze results for women with lower levels of urinary iodine, a potentially susceptible population. A second special attribute of the present study is the much larger sample size of women, affording more statistical power to detect a potential effect. By averaging over many women, the current data likely represents a good approximation of a population steady-state exposure to perchlorate that women have had for a long period of time. If a mid- to long-term exposure is needed for perchlorate to affect thyroid function, this data would have a better opportunity to detect that effect than study designs using short-term exposures. The influence of duration of exposure merits further study.

Accurate assessment of exposure is critical to detect biochemical end points potentially related to exposure. Our laboratory recently developed an improved method for measuring urinary perchlorate, which enhances individual perchlorate exposure assessment ([@b54-ehp0114-001865]). The use of this new urinary perchlorate measurement strengthens the ability of the present study to detect potential associations with T~4~ and TSH.

The present study has the general limitations of a cross-sectional analysis. Therefore, the relationship between urinary perchlorate and thyroid function was examined with attention to the potential influences of chance, bias, or confounding. Perchlorate (as with any of the significant predictor variables) could be a surrogate for another unrecognized determinant of thyroid function. We also assumed in this analysis that urinary perchlorate correlates with levels in the thyroid stroma and tissue, a kinetically distinct compartment. This would be the case in a population with stable, chronic exposures, which is likely but not certain in this population. A large sample size helps to average such potential kinetic differences. Finally, a measurement of free T~4~ would be an improvement to the study.

Conclusions
===========

Urinary perchlorate is associated with an increased TSH and decreased total T~4~ in women ≥ 12 years of age with urine iodine levels \< 100 μg/L in the U.S. population during 2001--2002. For women with urine iodine levels ≥ 100 μg/L, urine perchlorate is a significant predictor of TSH but not T~4~. These effects of perchlorate on T~4~ and TSH are coherent in direction and independent of other variables known to affect thyroid function, but are found at perchlorate exposure levels that were unanticipated based on previous studies. Further research is recommended to affirm these findings.
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###### 

Means and percent in category for covariates used in the multiple regression, women ≥ 12 years of age, NHANES 2001--2002.[a](#tfn2-ehp0114-001865){ref-type="table-fn"}

  Variable                           No.     No. missing   Arithmetic mean (95% CI)   Geometric mean (95% CI)   Percent in category (95% CI)
  ---------------------------------- ------- ------------- -------------------------- ------------------------- ------------------------------
  Age (years)                        1,111   0             39.8 (38.1--41.6)                                    
  Fasting (hr)                       1,111   0             10.4 (9.85--10.9)                                    
  Serum albumin (g/dL)               1,111   0             4.20 (4.17--4.23)                                    
  Serum T~4~ (μg/dL)                 1,111   0             8.27 (7.97--8.58)                                    
  Total kilocalories (kcal/1,000)    1,072   39            1.93 (1.87--1.99)                                    
  BMI                                1,075   36                                       25.8 (25.2--26.5)         
  Serum cotinine (μg/L)              1,104   7                                        0.33 (0.23--0.48)         
  Serum C-reactive protein (mg/dL)   1,111   0                                        0.16 (0.14--0.18)         
  Serum TSH (IU/L)                   1,111   0                                        1.36 (1.31--1.42)         
  Urine creatinine (mg/dL)           1,109   2                                        81.4 (76.7--86.5)         
  Urine iodine (μg/L)                1,111   0                                        126 (115--138)            
  Urine nitrate (μg/L × 1,000)       1,106   5                                        38.0 (35.9--40.3)         
  Urine perchlorate (μg/L)           1,111   0                                        2.84 (2.54--3.18)         
  Urine thiocyanate (μg/L × 1,000)   1,104   7                                        1.20 (1.08--1.33)         
  Race/ethnicity                                                                                                
   Non-Hispanic white                1,111   0                                                                  69.4 (62.9--75.4)
   Non-Hispanic black                1,111   0                                                                  12.5 (7.49--19.1)
   Mexican American                  1,111   0                                                                  7.02 (5.14--9.34)
   Other race                        1,111   0                                                                  11.1 (7.04--16.3)
  Medication usage                                                                                              
   Furosemide                        1,111   0                                                                  1.99 (1.25--3.01)
   Glucocorticoids and androgens     1,111   0                                                                  2.23 (1.24--3.67)
   Beta-blocker                      1,111   0                                                                  4.48 (3.34--5.87)
   Estrogen                          1,111   0                                                                  17.1 (13.2--21.7)
   Other drug                        1,111   0                                                                  1.04 (0.52--1.88)
  Menopausal or postmenopausal       1,028   83                                                                 35.9 (30.1--41.9)
  Pregnant                           1,111   0                                                                  3.84 (2.74--5.21)
  Premenarchal                       1,019   92                                                                 1.06 (0.48--2.02)

CI, confidence interval.

Excludes women with missing TSH, T~4~, or perchlorate, women with history of thyroid disease or taking thyroid drugs, and three women with outlier values of T~4~ or TSH (see text).

###### 

Regression of serum T~4~ on perchlorate and covariates for women ≥ 12 years of age with urine iodine \< 100 μg/L, NHANES 2001--2002.

  Independent variable                                             Coefficient   SE       *p*-Value
  ---------------------------------------------------------------- ------------- -------- -----------
  Intercept                                                        8.6508        0.5428   \< 0.0001
  Log (urinary perchlorate)                                        −0.8917       0.1811   \< 0.0001
  Log (urinary creatinine)                                         0.6897        0.3338   0.0391
  Estrogen use                                                     1.5117        0.4421   0.0007
  Log (C-reactive protein)                                         0.8249        0.1774   \< 0.0001
  Mexican American[a](#tfn4-ehp0114-001865){ref-type="table-fn"}   0.6296        0.3684   0.0878
  Menopause                                                        −0.5908       0.2578   0.0221
  Pregnant (by test)                                               0.7389        0.3662   0.0439
  Total kilocalorie intake (÷ 1,000)                               −0.3334       0.1173   0.0046
  Premenarche                                                      0.6401        0.2722   0.0189

Dependent variable: serum T~4~ (*n* = 348; *R*^2^ = 0.240).

Referent group for race is non-Hispanic white.

###### 

Regression of serum T~4~ on perchlorate and covariates for women ≥ 12 years of age with urine iodine ≥ 100 μg/L, NHANES 2001--2002.

  Independent variables                                            Coefficient   SE       *p*-Value
  ---------------------------------------------------------------- ------------- -------- -----------
  Intercept                                                        10.6652       1.2345   \< 0.0001
  Log (urinary perchlorate)                                        0.2203        0.3687   0.5503
  Log (urinary creatinine)                                         1.3138        0.7183   0.0677
  Estrogen use                                                     0.8278        0.2722   0.0024
  Log (C-reactive protein)                                         0.5783        0.1247   \< 0.0001
  Mexican-American[a](#tfn6-ehp0114-001865){ref-type="table-fn"}   0.5763        0.2522   0.0225
  Pregnant (by test)                                               1.6175        0.3334   \< 0.0001
  Log (urinary nitrate)                                            −1.1215       0.4994   0.0249
  Hours of fasting                                                 0.0290        0.0156   0.0630

Dependent variable: serum T~4~ (*n* = 724; *R*^2^ = 0.149).

Referent group for race is non-Hispanic white.

###### 

Regression of serum TSH on perchlorate and covariates for women ≥ 12 years of age with urine iodine \< 100 μg/L, NHANES 2001--2002.

  Independent variables       Coefficient   SE       *p*-Value
  --------------------------- ------------- -------- -----------
  Intercept                   0.2654        0.1183   0.0403
  Log (urinary perchlorate)   0.1230        0.0373   0.0010
  Log (urinary creatinine)    −0.0954       0.0761   0.2103
  Beta-blocker use            0.1881        0.0595   0.0016
  Estrogen use                −0.0918       0.0404   0.0233
  Premenarche                 0.1288        0.0262   \< 0.0001

Dependent variable: log of serum TSH (*n* = 356; *R*^2^ =0.061).

###### 

Regression of serum TSH on perchlorate and covariates for women ≥ 12 years of age with urine iodine ≥ 100 μg/L, NHANES 2001--2002.

  Independent variables                                              Coefficient   SE       *p*-Value
  ------------------------------------------------------------------ ------------- -------- -----------
  Intercept                                                          −0.6948       0.3415   0.0600
  Log (urinary perchlorate)                                          0.1137        0.0506   0.0249
  Log (urinary creatinine)                                           −0.1198       0.0910   0.1884
  Age in years                                                       0.0025        0.0006   \< 0.0001
  Log (BMI)                                                          0.4812        0.1346   0.0004
  Non-Hispanic black[a](#tfn9-ehp0114-001865){ref-type="table-fn"}   −0.1125       0.0335   0.0008
  Log (urinary nitrate)                                              0.1087        0.0591   0.0660
  Log (urinary thiocyanate)                                          −0.0816       0.0352   0.0206

Dependent variable: log of serum TSH (*n* = 697; *R*^2^ = 0.145).

Referent group for race is non-Hispanic white.

###### 

Predicted change in serum T~4~[a](#tfn10-ehp0114-001865){ref-type="table-fn"} and serum TSH[b](#tfn11-ehp0114-001865){ref-type="table-fn"} levels based on changes in urinary perchlorate levels in women ≥ 12 years of age, with urine iodine \< 100 μg/L, NHANES 2001--2002.

                                               Change in TSH (IU/L)[c](#tfn12-ehp0114-001865){ref-type="table-fn"}   
  ------------------------------------- ------ --------------------------------------------------------------------- ------
  0.19 to 0.65 μg/L (5th percentile)    0.48   0.23                                                                  0.51
  0.19 to 0.92 μg/L (10th percentile)   0.61   0.30                                                                  0.67
  0.19 to 1.6 μg/L (25th percentile)    0.83   0.42                                                                  0.93
  0.19 to 2.9 μg/L (50th percentile)    1.06   0.56                                                                  1.24
  0.19 to 5.2 μg/L (75th percentile)    1.28   0.70                                                                  1.56
  0.19 to 9.0 μg/L (90th percentile)    1.49   0.85                                                                  1.89
  0.19 to 13 μg/L (95th percentile)     1.64   0.95                                                                  2.12
  0.19 to 100 μg/L (maximum)            2.43   1.63                                                                  3.61

Normal range for T~4~: 5--12 μg/dL.

Normal range for TSH: 0.3--4.5 IU/L.

Depends on initial TSH level.

Minimum level measured, 0.19 μg/L.

###### 

Comparison of perchlorate studies targeting women or including a high percentage of women.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                              [@b23-ehp0114-001865]             [@b48-ehp0114-001865]                                        Present study
  ----------------------------------------------------------- --------------------------------- ------------------------------------------------------------ ----------------------------------
  No. of females studied                                      21 (37 total subjects)            184                                                          1,111

  No. of females with urine iodine \< 100 μg/L                Unknown (estimate 7--8)           3[a](#tfn14-ehp0114-001865){ref-type="table-fn"}             348, T~4~ analysis\
                                                                                                                                                             356, TSH analysis

  Females with urine iodine \< 100 μg/L analyzed separately   No                                No                                                           Yes

  Perchlorate dose and duration of exposure                   Up to 0.5 mg/kg/day for 14 days   Long-term environmental exposure                             Long-term environmental exposure

  Comments                                                                                      All women pregnant, increasing variability of T~4~ and TSH   
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Average of one to three spot urine samples.

[^1]: The authors declare they have no competing financial interests.
